Canine Diabetes Mellitus
MedVet is currently enrolling patients at three locations in a study evaluating the effectiveness and safety of a new insulin therapy that is given once a week.
Clinical Study Patient Eligibility
- Patient was recently diagnosed with diabetes or previously diagnosed with diabetes and currently receiving insulin
- Patient has not been seen or treated for DKA in the past month; if recently diagnosed with DKA, must be considered medically stable
- Patients cannot have uncontrolled concurrent conditions (well-controlled hyperadrenocorticism is okay)
- Patients cannot be resistant to insulin therapy.
Requirments of the Owner(s) of Study-Eligible Patients
- Must be able to return for all scheduled study visits
- Must monitor the patient’s clinical signs throughout the study
- Must be able to administer the medication as instructed
Study Information and Client savings
This study will cover visits with a Board-Certified Internal Medicine Specialist, medications, and laboratory testing at no cost to the owner. Set financial support for transition back to conventional insulin at the end of the trial will be provided.
CONTACTS
- MedVet Mandeville:
Jill Yates, DVM, Diplomate, ACVIM (SAIM)
im.mand@medvet.com or 985.626.4862
- MedVet Northern Virginia:
Sybille Miller, DVM, Diplomate, ACVIM (SAIM)
im.nova@medvet.com or 703.361.8287
- WestVet Boise:
Victoria Ochoa, DVM, MS, Diplomate, ACVIM (SAIM)
internalmedicine@westvet.net or 208.375.1600